We tested the prognostic power of mRNA expression of HIF1α, HIF2α and VEGFR2 in the publicly available RNA-Seq data of ccRCC from the TCGA project involving 399 patients (Figure 5). The gene discussed is HIF1A; the disease is nonpapillary renal cell carcinoma.